Skip to Main Content

Author Details

Ari Elson
The Weizmann Institute of Science
1989
75
31
PMIDPaper TitleJournal TitlePublished Year
37619639BASP1 down-regulates RANKL-induced osteoclastogenesis.Exp Cell Res2023
36028118The origins and formation of bone-resorbing osteoclasts.Bone2022
33975343An SNX10-dependent mechanism downregulates fusion between mature osteoclasts.J Cell Sci2021
33912557Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease.Front Cell Dev Biol2021
33605542PTPRJ promotes osteoclast maturation and activity by inhibiting Cbl-mediated ubiquitination of NFATc1 in late osteoclastogenesis.FEBS J2021
34746157Editorial: Developmental Biology and Regulation of Osteoclasts.Front Cell Dev Biol2021
34095139Sorting Nexin 10 as a Key Regulator of Membrane Trafficking in Bone-Resorbing Osteoclasts: Lessons Learned From Osteopetrosis.Front Cell Dev Biol2021
32278070Massive osteopetrosis caused by non-functional osteoclasts in R51Q SNX10 mutant mice.Bone2020
30615487Protein tyrosine phosphatase alpha inhibits hypothalamic leptin receptor signaling and regulates body weight in vivo.FASEB J2019
30026076The roles of protein tyrosine phosphatases in bone-resorbing osteoclasts.Biochim Biophys Acta Mol Cell Res2019
31357550Kinetic Modeling of DUSP Regulation in Herceptin-Resistant HER2-Positive Breast Cancer.Genes (Basel)2019
30952040Modelling the role of dual specificity phosphatases in herceptin resistant breast cancer cell lines.Comput Biol Chem2019
30622194Phosphorylation of the phosphatase PTPROt at Tyr<sup>399</sup> is a molecular switch that controls osteoclast activity and bone mass in vivo.Sci Signal2019
28941747Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases.Int J Biochem Cell Biol2018
29671404Regulation of dual specificity phosphatases in breast cancer during initial treatment with Herceptin: a Boolean model analysis.BMC Syst Biol2018
28166196The PTPROt tyrosine phosphatase functions as an obligate haploinsufficient tumor suppressor in vivo in B-cell chronic lymphocytic leukemia.Oncogene2017
27514812Production of Osteoclasts for Studying Protein Tyrosine Phosphatase Signaling.Methods Mol Biol2016
26414708Receptor Protein Tyrosine Phosphatase α-Mediated Enhancement of Rheumatoid Synovial Fibroblast Signaling and Promotion of Arthritis in Mice.Arthritis Rheumatol2016
27911712Regulation of receptor-type protein tyrosine phosphatases by their C-terminal tail domains.Biochem Soc Trans2016
24694598Protein tyrosine phosphatases ε and α perform nonredundant roles in osteoclasts.Mol Biol Cell2014
25381250Adaptor protein GRB2 promotes Src tyrosine kinase activation and podosomal organization by protein-tyrosine phosphatase ϵ in osteoclasts.J Biol Chem2014
25013399Metabolic regulation by protein tyrosine phosphatases.J Biomed Res2014
22938156Protein tyrosine phosphatases in health and disease.FEBS J2013
23756181Protein tyrosine phosphatases as novel targets in breast cancer therapy.Biochim Biophys Acta2013
22117074Epidermal growth factor receptor (EGFR)-mediated positive feedback of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and AKT protein pathways is required for survival of human breast cancer cells.J Biol Chem2012
22722941Multifaceted modulation of K+ channels by protein-tyrosine phosphatase ε tunes neuronal excitability.J Biol Chem2012
22851698Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.Mol Cell Biol2012
21531338Protein tyrosine phosphatase epsilon affects body weight by downregulating leptin signaling in a phosphorylation-dependent manner.Cell Metab2011
20195274Comment on Steven Rose's opinion article, 'Academic freedom in Israel and Palestine'.EMBO Rep2010
19508371Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.Scand J Immunol2009
19692574Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src.Mol Biol Cell2009
18093973Protein-tyrosine phosphatase epsilon regulates Shc signaling in a kinase-specific manner: increasing coherence in tyrosine phosphatase signaling.J Biol Chem2008
18924107PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells.Proteomics2008
18298790Protein tyrosine phosphatases: functional inferences from mouse models and human diseases.FEBS J2008
18231724Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis.Cancer Metastasis Rev2008
18342392Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption.Eur J Cell Biol2008
18006633Cytosolic protein tyrosine phosphatase-epsilon is a negative regulator of insulin signaling in skeletal muscle.Endocrinology2008
17486066Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells.Oncogene2007
17709387Association of tyrosine phosphatase epsilon with microtubules inhibits phosphatase activity and is regulated by the epidermal growth factor receptor.Mol Cell Biol2007
17341183Protein tyrosine phosphatases in osteoclasts.Crit Rev Eukaryot Gene Expr2007
16870705Tyrosine phosphatases epsilon and alpha perform specific and overlapping functions in regulation of voltage-gated potassium channels in Schwann cells.Mol Biol Cell2006
16715089Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells.Nat Med2006
14528021Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo.Mol Biol Cell2004
14966296Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase.Mol Cell Biol2004
14980517Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells.Exp Cell Res2004
12861030Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon.Mol Cell Biol2003
14674245Whole mount analysis of mammary gland structure in PTP epsilon transgenic mice.Methods Enzymol2003
12615930Phosphorylation-dependent regulation of Kv2.1 Channel activity at tyrosine 124 by Src and by protein-tyrosine phosphatase epsilon.J Biol Chem2003
12598528Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells.J Biol Chem2003
12754301Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases.Mol Cancer Res2003
  • 1 - 50 of 75

Recommended Authors

Yael Babichev
2Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital.
Career Start Year 2001
Number of shared co-authors 1
Danislav S Spassov
Faculty of Pharmacy, Medical University of Sofia
Career Start Year 2001
Number of shared co-authors 1
Stephane Angers
Department of Pharmaceutical Sciences, University of Toronto
Career Start Year 1999
Number of shared co-authors 0
Ian Pass
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1998
Number of shared co-authors 1
Charles James Hastie
University of Dundee
Career Start Year 1998
Number of shared co-authors 0
Lily Jun-Shen Huang
University of Texas Southwestern Medical Center
Career Start Year 1997
Number of shared co-authors 0
Andrew J Elia
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1995
Number of shared co-authors 2
Christopher Fladd
Hospital for Sick Children
Career Start Year 1994
Number of shared co-authors 0
Jiefei Tong
Hospital for Sick Children
Career Start Year 1993
Number of shared co-authors 3
Karen H Martin
West Virginia University Cancer Institute, West Virginia University
Career Start Year 1993
Number of shared co-authors 0
Dario R Alessi
University of Dundee
Career Start Year 1992
Number of shared co-authors 0
Ralph A Zirngibl
University of Toronto
Career Start Year 1990
Number of shared co-authors 0
Zhong-Yin Zhang
Center for Cancer Research, and Institute for Drug Discovery, Purdue University
Career Start Year 1990
Number of shared co-authors 1
Andrew Wakeham
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year 1989
Number of shared co-authors 2
Kun-Liang Guan
University of California San Diego
Career Start Year 1988
Number of shared co-authors 0
Rob Hooft van Huijsduijnen
Vrije Universiteit Amsterdam (VU)
Career Start Year 1987
Number of shared co-authors 0
Michael F Moran
Hospital for Sick Children, University of Toronto
Career Start Year 1985
Number of shared co-authors 3
Hamid Band
University of Nebraska Medical Center
Career Start Year 1985
Number of shared co-authors 0
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year 1984
Number of shared co-authors 0
Daniela Rotin
The Hospital for Sick Children
Career Start Year 1982
Number of shared co-authors 0
Sylvain Meloche
Institute for Research in Immunology and Cancer
Career Start Year 1982
Number of shared co-authors 0
James R Woodgett
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1982
Number of shared co-authors 2
Siu-Pok Yee
University of Connecticut Health Center
Career Start Year 1981
Number of shared co-authors 0
Donald L Durden
Atrium Health-Levine Cancer Institute
Career Start Year 1979
Number of shared co-authors 1
Michael C Ostrowski
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 1979
Number of shared co-authors 1
Sara A Courtneidge
Oregon Health & Science University
Career Start Year 1977
Number of shared co-authors 0
Jack E Dixon
University of California
Career Start Year 1972
Number of shared co-authors 1
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 2
Jonathan M Backer
Albert Einstein College of Medicine
Career Start Year 1970
Number of shared co-authors 0
Tony Hunter
Salk Institute for Biological Studies
Career Start Year 1968
Number of shared co-authors 0

Collaborators

Benjamin Geiger
Co-authored papers 3
David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Co-authored papers 2
Cynthia C Morton
Co-authored papers 2
German R Aleman Muench
Co-authored papers 1
Niloofar Arshadi
Dalla Lana School of Public Health, University of Toronto
Co-authored papers 1
Dennis J Wu
Co-authored papers 1
Irina Kalatskaya
EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA)
Co-authored papers 1
Shawn S-C Li
University of Western Ontario
Co-authored papers 1
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Bin Xue
University of California at Berkeley
Co-authored papers 1
Senthil K Muthuswamy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Michel L Tremblay
Co-authored papers 1
Nunzio Bottini
Co-authored papers 1
Cristiano Sacchetti
Co-authored papers 1
David L Boyle
Co-authored papers 1
Gary S Firestein
Co-authored papers 1
Syed Haider
Institute of Cancer Research
Co-authored papers 1
Nicholas K Tonks
University of Washington
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Piotr Mydel
Co-authored papers 1
Francis Nguyen
Ontario Institute for Cancer Research
Co-authored papers 1
Lakshmi Muthuswamy
Harvard Medical School
Co-authored papers 1
Stephanie M Stanford
Co-authored papers 1
Timothy F Lane
Co-authored papers 1
Mattias N D Svensson
Co-authored papers 1
Guang Lin
Baylor College of Medicine
Co-authored papers 1
Maripat Corr
Co-authored papers 1
Lawrence A Donehower
Baylor College of Medicine
Co-authored papers 1
Min Yu
The Rockefeller University
Co-authored papers 1
Release 1.2